BioLight Life Sciences Ltd. (TLV:BOLT)
Israel · Delayed Price · Currency is ILS · Price in ILA 399.70
-6.20 (-1.53%)
Nov 6, 2025, 5:26 PM IDT
BioLight Life Sciences Revenue
BioLight Life Sciences had revenue of 105.00K ILS in the twelve months ending June 30, 2025, down -46.97% year-over-year. In the year 2024, BioLight Life Sciences had annual revenue of 219.00K with 85.59% growth.
Revenue (ttm)
105.00K
Revenue Growth
-46.97%
P/S Ratio
178.51
Revenue / Employee
26.25K
Employees
4
Market Cap
18.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 219.00K | 101.00K | 85.59% |
| Dec 31, 2023 | 118.00K | 55.00K | 87.30% |
| Dec 31, 2022 | 63.00K | 60.00K | 2,000.00% |
| Dec 31, 2021 | 3.00K | -28.00K | -90.32% |
| Dec 31, 2020 | 31.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Danel (Adir Yeoshua) | 2.84B |
| Novolog (Pharm-Up 1966) | 2.04B |
| Ilex Medical | 927.57M |
| Kamada | 571.15M |
| InterCure | 243.12M |
| SofWave Medical | 234.12M |
| BrainsWay | 155.27M |